ACRS icon

Aclaris Therapeutics
ACRS

Overview Fund Activity

95 hedge funds and large institutions have $130M invested in Aclaris Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 27 reducing their positions, and 36 closing their positions.

Holders
95
Holders Change
-13
Holders Change %
-12.04%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
24
Increased
30
Reduced
27
Closed
36
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
-$29K

Top Buyers

1
BlackRock
1
BlackRock
New York
$7.83M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$9.46M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$3.5M
4
Morgan Stanley
4
Morgan Stanley
New York
$5.03M
5
PAI
5
Palo Alto Investors
California
$1.97M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
MIM
2
Monashee Investment Management
Massachusetts
$0
3
Qube Research & Technologies (QRT)
3
Qube Research & Technologies (QRT)
United Kingdom
$723K
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$262K
5
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$0
Name Market Value Shares Shares
Change 		Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
$886K 623,792 +125,071 +25%
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
$723K 509,350 -841,470 -62%
SCM
28
Stonepine Capital Management
Oregon
$698K 491,300 -36,542 -7%
CF
29
Cantor Fitzgerald
New York
$641K 451,120 -244,453 -35%
BCM
30
Bridgeway Capital Management
Texas
$630K 443,319 +154,600 +54%
Fidelity Investments
31
Fidelity Investments
Massachusetts
$628K 442,247 -15,937 -3%
ACM
32
Aisling Capital Management
New York
$617K 434,455 – –
Squarepoint
33
Squarepoint
New York
$555K 390,583 +41,666 +12%
HighTower Advisors
34
HighTower Advisors
Illinois
$457K 321,817 +5,753 +2%
Raymond James Financial
35
Raymond James Financial
Florida
$394K 277,259 +26,454 +11%
Charles Schwab
36
Charles Schwab
California
$371K 261,298 +228,219 +690%
NL
37
Nuveen LLC
North Carolina
$338K 237,830 +237,830 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$306K 215,262 +201,689 +1,486%
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$295K 207,273 -147,576 -42%
Assenagon Asset Management
40
Assenagon Asset Management
Luxembourg
$262K 184,585 -496,968 -73%
T. Rowe Price Associates
41
T. Rowe Price Associates
Maryland
$237K 166,367 +43,267 +35%
Goldman Sachs
42
Goldman Sachs
New York
$222K 156,572 -399,381 -72%
Barclays
43
Barclays
United Kingdom
$222K 156,337 +37,336 +31%
UBS Group
44
UBS Group
Switzerland
$218K 153,172 +79,180 +107%
Invesco
45
Invesco
Georgia
$192K 135,329 +78,250 +137%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$121K 84,965 +84,965 New
Bank of America
47
Bank of America
North Carolina
$103K 72,595 -95,074 -57%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$91K 64,200 +64,200 New
Wells Fargo
49
Wells Fargo
California
$89.2K 62,840 +58,250 +1,269%
MIM
50
MetLife Investment Management
New Jersey
$80K 56,344 +56,344 New
1
2
3 4 5